Aptose Biosciences, Inc. (APTO) Social Stream



Aptose Biosciences, Inc. (APTO): $0.36

0.02 (-5.53%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add APTO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#101 of 362

in industry

APTOSE BIOSCIENCES INC (APTO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering APTO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 3 $10 $7 $8.75 $2.29 282.1%
2021-11-12 3 $14 $7 $10 $2.29 336.68%
2021-12-14 4 $14 $7 $10 $2.29 336.68%
2021-12-21 3 $12 $3 $8.5 $2.29 271.18%
2022-06-06 4 $12 $3 $8.5 $2.29 271.18%
2022-08-03 4 $12 $3 $7.5 $2.29 227.51%
2022-09-12 3 $12 $3 $8 $2.29 249.34%
2022-11-02 6 $12 $3 $8 $2.29 249.34%
2023-03-27 6 $13 $3 $8 $2.29 249.34%
2023-05-09 6 $179.91 $44.977 $109.23 $2.29 4669.87%
2023-06-07 6 $179.91 $37 $103.096 $2.29 4402.01%
2023-08-11 6 $119.94 $12 $52.554 $2.29 2194.93%
2023-11-10 6 $38 $12 $21 $2.29 817.03%

The Trend in the Analyst Price Target


APTO's average price target has moved up $9.1 over the prior 15 months.

Over the past 41 weeks, APTO's average upside potential has been 2,131.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-30 6 13.00 3 8.000 0.741 979.62%
2023-05-09 6 12.00 3 7.285 0.510 1328.43%
2023-08-11 6 119.94 12 50.125 4.350 1052.3%
2023-11-10 5 23.00 12 16.600 2.450 577.55%
2023-11-10 6 38.00 12 21.000 2.450 757.14%

APTO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 4 1 0 0 0 5

The Trend in the Broker Recommendations


Over the past 14 months, APTO's average broker recommendation rating worsened by 0.2.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • APTO has a greater upside potential (average analyst target price relative to current price) than 1762.37% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, APTOSE BIOSCIENCES INC's variance in analysts' estimates is lower than -1566.18% of them.
  • In the context of all US stocks, APTOSE BIOSCIENCES INC's average analyst price target is higher than 464.81% of them.
  • In the context of Healthcare stocks, APTOSE BIOSCIENCES INC's number of analysts covering the stock is higher than 468.49% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to APTOSE BIOSCIENCES INC are CLLS, ADAP, and OTLK.

Is APTO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!